Effect of Liuzijue on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: study protocol for a multicenter, non-randomized, prospective study

[1] Singh D(2019)Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019 Eur Respir J 53 1900164-1717

[2] Agusti A(2018)Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study Lancet 391 1706-515

[3] Anzueto A(2011)Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach Eur Respir J 37 508-955

[4] Barnes PJ(2013)High-risk patients following hospitalisation for an acute exacerbation of COPD Eur Respir J 42 946-e62

[5] Bourbeau J(2014)An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease Am J Respir Crit Care Med 189 e15-933

[6] Celli BR(2015)Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 192 924-2679

[7] Criner GJ(2016)Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes Int J Chron Obstruct Pulmon Dis Volume 11 2671-e64

[8] Frith P(2021)Individualized, low-cost and accessible pulmonary rehabilitation program based on functional clinical tests for individuals with COPD-a study protocol of a randomized controlled trial Trials 22 367-1386

[9] Halpin DMG(2013)An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation Am J Respir Crit Care Med 188 e13-526

[10] Han M(2015)An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation Am J Respir Crit Care Med 192 1373-e695

[1] Singh D(2019)Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019 Eur Respir J 53 1900164-1717

[2] Agusti A(2018)Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study Lancet 391 1706-515

[3] Anzueto A(2011)Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach Eur Respir J 37 508-955

[4] Barnes PJ(2013)High-risk patients following hospitalisation for an acute exacerbation of COPD Eur Respir J 42 946-e62

[5] Bourbeau J(2014)An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease Am J Respir Crit Care Med 189 e15-933

[6] Celli BR(2015)Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 192 924-2679

[7] Criner GJ(2016)Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes Int J Chron Obstruct Pulmon Dis Volume 11 2671-e64

[8] Frith P(2021)Individualized, low-cost and accessible pulmonary rehabilitation program based on functional clinical tests for individuals with COPD-a study protocol of a randomized controlled trial Trials 22 367-1386

[9] Halpin DMG(2013)An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation Am J Respir Crit Care Med 188 e13-526

[10] Han M(2015)An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation Am J Respir Crit Care Med 192 1373-e695